PDCD1LG2 and hepatocellular carcinoma: In the validation, RIN1 specifically inhibited PD-L1 expression in HCC cells (Figs. 6a-e, Supplementary Fig. 9a), but had no effect on PD-L2 and MHC-I molecules (Supplementary Fig. 9b, c).